BioCentury
ARTICLE | Clinical News

PF-4950615: Phase I data

November 19, 2012 8:00 AM UTC

A double-blind, U.S. Phase I trial in 67 diet-managed patients with hypercholesterolemia, including 9 of Japanese ancestry, showed that RN316 was generally well tolerated with infrequent and transient...